Meta Platforms
META
Alphabet-C
GOOG
Alphabet-A
GOOGL
4
Vale SA
VALE
5
Coinbase
COIN
US Stock MarketDetailed Quotes
CTRVP HEPION PHARMACEUTICALS INC PREFERRED STOCK
- 0.000
- 0.0000.00%
15min DelayClose Jul 5 09:33 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.00052wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM0Shs Float0.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
HEPION PHARMACEUTICALS INC PREFERRED STOCK Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -58.20%4.46M | -39.97%8.5M | -60.77%5.18M | 3.76%45.26M | -26.14%7.22M | 25.98%10.66M | -21.85%14.17M | 82.13%13.21M | 43.46%43.62M | 8.59%9.77M |
| Selling and administrative expenses | -20.99%1.7M | -40.17%1.37M | -22.53%2.64M | -7.06%9.62M | -21.31%1.78M | -21.25%2.15M | -5.78%2.28M | 15.98%3.41M | 3.40%10.35M | 7.98%2.26M |
| -General and administrative expense | -20.99%1.7M | -40.17%1.37M | -22.53%2.64M | -7.06%9.62M | -21.31%1.78M | -21.25%2.15M | -5.78%2.28M | 15.98%3.41M | 3.40%10.35M | 7.98%2.26M |
| Research and development costs | -67.57%2.76M | -39.93%7.14M | -74.08%2.54M | 7.12%35.64M | -27.58%5.44M | 48.40%8.52M | -24.34%11.88M | 127.26%9.8M | 63.12%33.27M | 8.77%7.52M |
| Operating profit | 58.20%-4.46M | 39.97%-8.5M | 60.77%-5.18M | -3.76%-45.26M | 26.14%-7.22M | -25.98%-10.66M | 21.85%-14.17M | -82.13%-13.21M | -43.46%-43.62M | -8.59%-9.77M |
| Net non-operating interest income expense | -19,831.54%-474.57K | 2,207.02%49.54K | -87.30%-4.35K | 6.88%-9.47K | 4.02%-2.41K | -5.12%-2.38K | 26.02%-2.35K | -5.12%-2.32K | -14.73%-10.16K | -15.12%-2.51K |
| Non-operating interest expense | ---- | ---- | 87.30%4.35K | -6.88%9.47K | ---- | ---- | ---- | 5.12%2.32K | 14.73%10.16K | ---- |
| Total other finance cost | 19,831.54%474.57K | -2,207.02%-49.54K | ---- | ---- | ---- | 5.12%2.38K | --2.35K | ---- | ---- | ---- |
| Other net income (expense) | -52.23%66.88K | 5,021.45%4.53M | -1,213.94%-636.39K | -179.38%-4.07M | -5,409.56%-4.25M | 275.00%140K | 104.97%88.43K | -114.90%-48.43K | 36.97%-1.46M | 111.11%80K |
| Gain on sale of security | ---- | ---- | ---2.57M | -311.48%-877.65K | ---- | ---- | ---- | ---- | 117.97%414.99K | ---- |
| Special income (charges) | -52.23%66.88K | 5,021.45%4.53M | 4,086.15%1.93M | -70.50%-3.19M | -905.99%-3.37M | 275.00%140K | 104.97%88.43K | -114.90%-48.43K | ---1.87M | -121.07%-334.99K |
| -Less：Restructuring and merger&acquisition | 52.23%-66.88K | -5,021.45%-4.53M | -4,086.15%-1.93M | ---- | ---- | -275.00%-140K | 1.74%-88.43K | 114.90%48.43K | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | 70.50%3.19M | ---- | ---- | ---- | ---- | --1.87M | --0 |
| Income before tax | 53.78%-4.87M | 72.12%-3.93M | 56.09%-5.82M | -9.43%-49.34M | -18.29%-11.47M | -23.16%-10.53M | 29.29%-14.08M | -91.35%-13.26M | -37.78%-45.08M | 0.28%-9.7M |
| Income tax | 0 | 0 | -2.97M | 85.82%-409.02K | 85.82%-409.02K | 0 | 0 | 0 | -2.88M | -2.88M |
| Net income | 53.78%-4.87M | 72.12%-3.93M | 78.48%-2.85M | -15.94%-48.93M | -62.37%-11.06M | -23.16%-10.53M | 29.29%-14.08M | -91.35%-13.26M | -28.96%-42.2M | 29.94%-6.81M |
| Net income continuous Operations | 53.78%-4.87M | 72.12%-3.93M | 78.48%-2.85M | -15.94%-48.93M | -62.37%-11.06M | -23.16%-10.53M | 29.29%-14.08M | -91.35%-13.26M | -28.96%-42.2M | 29.94%-6.81M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 53.78%-4.87M | 72.12%-3.93M | 78.48%-2.85M | -15.94%-48.93M | -62.37%-11.06M | -23.16%-10.53M | 29.29%-14.08M | -91.35%-13.26M | -28.96%-42.2M | 29.94%-6.81M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 3.14M | ||||||||
| Net income attributable to common stockholders | 53.78%-4.87M | 72.12%-3.93M | 78.48%-2.85M | -7.92%-48.93M | -11.16%-11.06M | -23.16%-10.53M | 29.29%-14.08M | -91.35%-13.26M | -38.55%-45.34M | -2.33%-9.95M |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now